|
|
Prepublished online as a Blood First Edition Paper on October 17, 2002; DOI 10.1182/blood-2002-07-2238.
Previous Article | Table of Contents | Next Article 
Blood, 15 February 2003, Vol. 101, No. 4, pp. 1284-1289
GENE THERAPY
Lentiviral vector transduction of NOD/SCID repopulating cells
results in multiple vector integrations per transduced cell: risk of
insertional mutagenesis
Niels-Bjarne Woods,
Arne Muessig,
Manfred Schmidt,
Johan Flygare,
Karin Olsson,
Patrick Salmon,
Didier Trono,
Christof von
Kalle, and
Stefan Karlsson
From the Department for Molecular Medicine and
Gene Therapy, Institute of Laboratory Medicine, Lund University, Lund,
Sweden; the Department I of Internal Medicine and
Institute for Molecular Medicine and Cell Research, University of
Freiburg, Freiburg, Germany; the Department of Genetics
and Microbiology, University of Geneva Medical School, Geneva,
Switzerland; the Program for Molecular and Gene Therapy, Division of
Experimental Hematology, Cincinnati Children's Hospital Research
Foundation, Cincinnati, OH.
Efficient vector transduction of hematopoietic stem cells is a
requirement for successful gene therapy of hematologic disorders. We
asked whether human umbilical cord blood
CD34+CD38lo nonobese diabetic/severe
combined immunodeficiency (NOD/SCID) repopulating cells (SRCs) could be
efficiently transduced using lentiviral vectors, with a particular
focus on the average number of vector copies integrating into these
primitive progenitor cells. Mouse bone marrow was analyzed by
fluorescence-activated cell-sorter scanner and by
semiquantitative polymerase chain reaction (PCR) to determine
the transduction efficiency into SRCs. Lentiviral vector transduction
resulted in an average of 22% (range, 3%-90%) of the human cells
expressing green fluorescent protein (GFP), however, multiple
vector copies were present in human hematopoietic cells, with an
average of 5.6 ± 3.3 (n = 12) copies per transduced cell. To
confirm the ability of lentiviral vectors to integrate multiple
vector copies into SRCs, linear amplification mediated (LAM)-PCR was
used to analyze the integration site profile of a selected mouse
showing low-level engraftment and virtually all human cells expressing
GFP. Individually picked granulocyte macrophage colony-forming
unit colonies derived from the bone marrow of this mouse were
analyzed and shown to have the same 5 vector integrants within each
colony. Interestingly, one integration site of the 5 that were
sequenced in this mouse was located in a known tumor-suppressor gene,
BRCA1. Therefore, these findings demonstrate the ability of
lentiviral vectors to transduce multiple copies into a subset of
NOD/SCID repopulating cells. While this is efficient in terms of
transduction and transgene expression, it may increase the risk of
insertional mutagenesis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Kieback, J. Charo, D. Sommermeyer, T. Blankenstein, and W. Uckert
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer
PNAS,
January 15, 2008;
105(2):
623 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood,
January 15, 2008;
111(2):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-P. Kiem, J. Allen, G. Trobridge, E. Olson, K. Keyser, L. Peterson, and D. W. Russell
Foamy virus-mediated gene transfer to canine repopulating cells
Blood,
January 1, 2007;
109(1):
65 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Van Damme, L. Thorrez, L. Ma, H. Vandenburgh, J. Eyckmans, F. Dell'Accio, C. De Bari, F. Luyten, D. Lillicrap, D. Collen, et al.
Efficient Lentiviral Transduction and Improved Engraftment of Human Bone Marrow Mesenchymal Cells
Stem Cells,
April 1, 2006;
24(4):
896 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Miyake, A. C.M. Brun, M. Magnusson, K. Miyake, D. T. Scadden, and S. Karlsson
HOXB4-Induced Self-Renewal of Hematopoietic Stem Cells Is Significantly Enhanced by p21 Deficiency
Stem Cells,
March 1, 2006;
24(3):
653 - 661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Verhoeyen, M. Wiznerowicz, D. Olivier, B. Izac, D. Trono, A. Dubart-Kupperschmitt, and F.-L. Cosset
Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells
Blood,
November 15, 2005;
106(10):
3386 - 3395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Bot, J. Guo, M. Van Eck, P. J. Van Santbrink, P. H. E. Groot, R. B. Hildebrand, J. Seppen, T. J. C. Van Berkel, and E. A. L. Biessen
Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo
Blood,
August 15, 2005;
106(4):
1147 - 1153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Modlich, O. S. Kustikova, M. Schmidt, C. Rudolph, J. Meyer, Z. Li, K. Kamino, N. von Neuhoff, B. Schlegelberger, K. Kuehlcke, et al.
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis
Blood,
June 1, 2005;
105(11):
4235 - 4246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hanawa, P. W. Hargrove, S. Kepes, D. K. Srivastava, A. W. Nienhuis, and D. A. Persons
Extended {beta}-globin locus control region elements promote consistent therapeutic expression of a {gamma}-globin lentiviral vector in murine {beta}-thalassemia
Blood,
October 15, 2004;
104(8):
2281 - 2290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Davis, L. Humeau, V. Slepushkin, G. Binder, L. Korshalla, Y. Ni, E. O. Ogunjimi, L.-F. Chang, X. Lu, and B. Dropulic
ABC transporter inhibitors that are substrates enhance lentiviral vector transduction into primitive hematopoietic progenitor cells
Blood,
July 15, 2004;
104(2):
364 - 373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hanawa, P. Hematti, K. Keyvanfar, M. E. Metzger, A. Krouse, R. E. Donahue, S. Kepes, J. Gray, C. E. Dunbar, D. A. Persons, et al.
Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system
Blood,
June 1, 2004;
103(11):
4062 - 4069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Horn, K. A. Keyser, L. J. Peterson, T. Neff, B. M. Thomasson, J. Thompson, and H.-P. Kiem
Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol
Blood,
May 15, 2004;
103(10):
3710 - 3716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mazurier, O. I. Gan, J. L. McKenzie, M. Doedens, and J. E. Dick
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
Blood,
January 15, 2004;
103(2):
545 - 552.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. S. Kustikova, A. Wahlers, K. Kuhlcke, B. Stahle, A. R. Zander, C. Baum, and B. Fehse
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population
Blood,
December 1, 2003;
102(12):
3934 - 3937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Geronimi, E. Richard, I. Redonnet-Vernhet, I. Lamrissi-Garcia, M. Lalanne, C. Ged, F. Moreau-Gaudry, and H. de Verneuil
Highly Efficient Lentiviral Gene Transfer in CD34+ and CD34+/38-/lin- Cells from Mobilized Peripheral Blood after Cytokine Prestimulation
Stem Cells,
July 1, 2003;
21(4):
472 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ramezani, T. S. Hawley, and R. G. Hawley
Performance- and safety-enhanced lentiviral vectors containing the human interferon-{beta} scaffold attachment region and the chicken {beta}-globin insulator
Blood,
June 15, 2003;
101(12):
4717 - 4724.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|